136 related articles for article (PubMed ID: 38536042)
1. Genetic variation in severe cystic fibrosis liver disease is associated with novel mechanisms for disease pathogenesis.
Stonebraker JR; Pace RG; Gallins PJ; Dang H; Aksit MA; Faino AV; Gordon WW; MacParland S; Bamshad MJ; Gibson RL; Cutting GR; Durie PR; Wright FA; Zhou YH; Blackman SM; O'Neal WK; Ling SC; Knowles MR
Hepatology; 2024 Mar; ():. PubMed ID: 38536042
[TBL] [Abstract][Full Text] [Related]
2. Genetic modifiers of liver disease in cystic fibrosis.
Bartlett JR; Friedman KJ; Ling SC; Pace RG; Bell SC; Bourke B; Castaldo G; Castellani C; Cipolli M; Colombo C; Colombo JL; Debray D; Fernandez A; Lacaille F; Macek M; Rowland M; Salvatore F; Taylor CJ; Wainwright C; Wilschanski M; Zemková D; Hannah WB; Phillips MJ; Corey M; Zielenski J; Dorfman R; Wang Y; Zou F; Silverman LM; Drumm ML; Wright FA; Lange EM; Durie PR; Knowles MR;
JAMA; 2009 Sep; 302(10):1076-83. PubMed ID: 19738092
[TBL] [Abstract][Full Text] [Related]
3. SERPINA1 Z allele is associated with cystic fibrosis liver disease.
Boëlle PY; Debray D; Guillot L; Corvol H;
Genet Med; 2019 Sep; 21(9):2151-2155. PubMed ID: 30739910
[TBL] [Abstract][Full Text] [Related]
4. Clinical and genetic risk factors for cystic fibrosis-related liver disease in Egyptian CF children: A single-center experience.
El-Faramawy A; Nasr SZ; Emam MMSA; Fahmy HMH
Pediatr Pulmonol; 2024 Feb; 59(2):465-471. PubMed ID: 38038166
[TBL] [Abstract][Full Text] [Related]
5. Cystic fibrosis related liver disease and endocrine considerations.
Sherwood JS; Ullal J; Kutney K; Hughan KS
J Clin Transl Endocrinol; 2022 Mar; 27():100283. PubMed ID: 35024343
[TBL] [Abstract][Full Text] [Related]
6. Characterization of CFTR mutations in people with cystic fibrosis and severe liver disease who are not eligible for CFTR modulators.
Colombo C; Ramm GA; Lindblad A; Corti F; Porcaro L; Alghisi F; Asherova I; Evans H; Kashirskaya N; Kondratyeva E; Lewindon PJ; de Monestrol I; Oliver M; Ooi CY; Padoan R; Shankar S; Alicandro G
J Cyst Fibros; 2023 Mar; 22(2):263-265. PubMed ID: 36739240
[TBL] [Abstract][Full Text] [Related]
7. Cystic fibrosis rabbits develop spontaneous hepatobiliary lesions and CF-associated liver disease (CFLD)-like phenotypes.
Wu Q; Liang X; Hou X; Song Z; Bouhamdan M; Qiu Y; Koike Y; Rajagopalan C; Wei HG; Jiang H; Hish G; Zhang J; Chen YE; Jin JP; Xu J; Zhang K; Sun F
PNAS Nexus; 2023 Jan; 2(1):pgac306. PubMed ID: 36712930
[TBL] [Abstract][Full Text] [Related]
8. Prominent role of gut dysbiosis in the pathogenesis of cystic fibrosis-related liver disease in mice.
Bertolini A; Nguyen M; Zehra SA; Taleb SA; Bauer-Pisani T; Palm N; Strazzabosco M; Fiorotto R
J Hepatol; 2024 Mar; ():. PubMed ID: 38554847
[TBL] [Abstract][Full Text] [Related]
9. Cystic fibrosis-associated liver disease in children.
Wasuwanich P; Karnsakul W
Minerva Pediatr; 2020 Oct; 72(5):440-447. PubMed ID: 32418413
[TBL] [Abstract][Full Text] [Related]
10. Liver disease in cystic fibrosis.
Kobelska-Dubiel N; Klincewicz B; Cichy W
Prz Gastroenterol; 2014; 9(3):136-41. PubMed ID: 25097709
[TBL] [Abstract][Full Text] [Related]
11. Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population.
Polineni D; Piccorelli AV; Hannah WB; Dalrymple SN; Pace RG; Durie PR; Ling SC; Knowles MR; Stonebraker JR
PLoS One; 2018; 13(10):e0205257. PubMed ID: 30307979
[TBL] [Abstract][Full Text] [Related]
12. Modifier genes in cystic fibrosis-related liver disease.
Debray D; Corvol H; Housset C
Curr Opin Gastroenterol; 2019 Mar; 35(2):88-92. PubMed ID: 30585791
[TBL] [Abstract][Full Text] [Related]
13. Controlled attenuation parameter: A measure of hepatic steatosis in patients with cystic fibrosis.
Bader RM; Jonas MM; Mitchell PD; Wiggins S; Lee CK
J Cyst Fibros; 2019 Mar; 18(2):280-285. PubMed ID: 30509601
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional basis for hepatic fibrosis in cystic fibrosis-associated liver disease.
Pereira TN; Lewindon PJ; Greer RM; Hoskins AC; Williamson RM; Shepherd RW; Ramm GA
J Pediatr Gastroenterol Nutr; 2012 Mar; 54(3):328-35. PubMed ID: 22157922
[TBL] [Abstract][Full Text] [Related]
15. Gamma-glutamyl transpeptidase-to-platelet ratio as a biomarker of liver disease and hepatic fibrosis severity in paediatric Cystic Fibrosis.
Calvopina DA; Lewindon PJ; Ramm LE; Noble C; Hartel GF; Leung DH; Ramm GA
J Cyst Fibros; 2022 Mar; 21(2):236-242. PubMed ID: 34953741
[TBL] [Abstract][Full Text] [Related]
16. The natural history of cystic fibrosis liver disease a prospective cohort study.
Rowland M; Drummond J; Connolly L; Daly E; McCormick PA; Bourke B; ;
J Cyst Fibros; 2023 Nov; 22(6):1054-1061. PubMed ID: 37495468
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and characteristics of cystic fibrosis liver disease: a study highlighting the lack of histological diagnosis.
Issa Z; Gohy S; Zech F; Baldin P; Delire B; Dahlqvist G
Clin Res Hepatol Gastroenterol; 2022 Nov; 46(9):101977. PubMed ID: 35772685
[TBL] [Abstract][Full Text] [Related]
18. Single-cell RNA sequencing of cystic fibrosis liver disease explants reveals endothelial complement activation.
Declercq M; Treps L; Geldhof V; Conchinha NV; de Rooij LPMH; Subramanian A; Feyeux M; Cotinat M; Boeckx B; Vinckier S; Dupont L; Vermeulen F; Boon M; Proesmans M; Libbrecht L; Pirenne J; Monbaliu D; Jochmans I; Dewerchin M; Eelen G; Roskams T; Verleden S; Lambrechts D; Carmeliet P; Witters P
Liver Int; 2024 Jun; ():. PubMed ID: 38847551
[TBL] [Abstract][Full Text] [Related]
19. Review article: epidemiology, pathogenesis and management of liver disease in adults with cystic fibrosis.
Scott J; Jones AM; Piper Hanley K; Athwal VS
Aliment Pharmacol Ther; 2022 Feb; 55(4):389-400. PubMed ID: 35048397
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA Sequencing Identifies a Serum MicroRNA Panel, Which Combined With Aspartate Aminotransferase to Platelet Ratio Index Can Detect and Monitor Liver Disease in Pediatric Cystic Fibrosis.
Calvopina DA; Chatfield MD; Weis A; Coleman MA; Fernandez-Rojo MA; Noble C; Ramm LE; Leung DH; Lewindon PJ; Ramm GA
Hepatology; 2018 Dec; 68(6):2301-2316. PubMed ID: 30014495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]